GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (OTCPK:PFGTF) » Definitions » EPS without NRI

Pacific Edge (Pacific Edge) EPS without NRI : $-0.02 (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Pacific Edge EPS without NRI?

Pacific Edge's earnings per share without non-recurring items for the six months ended in Mar. 2024 was $-0.01. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.02.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -21.60% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Pacific Edge's EPS without NRI or its related term are showing as below:

PFGTF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -26   Med: -3   Max: 35.2
Current: -21.6

During the past 13 years, Pacific Edge's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 35.20% per year. The lowest was -26.00% per year. And the median was -3.00% per year.

PFGTF's 3-Year EPS without NRI Growth Rate is ranked worse than
75.29% of 170 companies
in the Medical Diagnostics & Research industry
Industry Median: -0.5 vs PFGTF: -21.60

Pacific Edge's EPS (Diluted) for the six months ended in Mar. 2024 was $-0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.02.

Pacific Edge's EPS (Basic) for the six months ended in Mar. 2024 was $-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.02.


Pacific Edge EPS without NRI Historical Data

The historical data trend for Pacific Edge's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge EPS without NRI Chart

Pacific Edge Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.01 -0.02 -0.02 -0.02

Pacific Edge Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.01 -0.01 -0.01 -0.01

Competitive Comparison of Pacific Edge's EPS without NRI

For the Diagnostics & Research subindustry, Pacific Edge's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Edge's PE Ratio without NRI Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Pacific Edge's PE Ratio without NRI falls into.



Pacific Edge EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pacific Edge  (OTCPK:PFGTF) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Pacific Edge EPS without NRI Related Terms

Thank you for viewing the detailed overview of Pacific Edge's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Edge (Pacific Edge) Business Description

Traded in Other Exchanges
Address
87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016
Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.

Pacific Edge (Pacific Edge) Headlines

From GuruFocus

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Full Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2021 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2023 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Trading Halt Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Half Year 2024 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 Pacific Edge Ltd Earnings Call Transcript

By GuruFocus Research 02-14-2024

Pacific Edge Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024